植入式心脏复律除颤器及心脏再同步治疗在心力衰竭管理中的概述。
Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
作者信息
Chia Pow-Li, Foo David
机构信息
Department of Cardiology, Tan Tock Seng Hospital, Singapore.
出版信息
Singapore Med J. 2016 Jul;57(7):354-9. doi: 10.11622/smedj.2016117.
Abstract
Clinical trials have established the benefits of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in the treatment of heart failure patients. As adjuncts to guideline-directed medical therapy, ICDs confer mortality benefits from sudden cardiac arrest, while CRT reduces mortality, hospitalisation rates and improves functional capacity. This review discusses the use of ICDs and CRT devices in heart failure management, outlining the evidence supporting their use, indications and contraindications.
摘要
临床试验已证实植入式心脏复律除颤器（ICD）和心脏再同步治疗（CRT）在治疗心力衰竭患者方面的益处。作为指南指导药物治疗的辅助手段，ICD可降低心脏骤停导致的死亡率，而CRT可降低死亡率、住院率并改善功能能力。本综述讨论了ICD和CRT设备在心力衰竭管理中的应用，概述了支持其使用的证据、适应证和禁忌证。
相似文献
1
Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.植入式心脏复律除颤器及心脏再同步治疗在心力衰竭管理中的概述。
Singapore Med J. 2016 Jul;57(7):354-9. doi: 10.11622/smedj.2016117.
2
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗：系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
3
Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.2006 年至 2008 年期间，国家心血管数据注册中心接受心脏再同步治疗除颤器植入术的患者中，指南指导的药物治疗的流行率。
Am J Cardiol. 2014 Jun 15;113(12):2052-6. doi: 10.1016/j.amjcard.2014.03.049. Epub 2014 Apr 1.
4
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.心力衰竭男性和女性心脏再同步和植入式心脏复律除颤器治疗的临床效果：来自 IMPROVE HF 的研究结果。
Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31.
5
Newer Indications for ICD and CRT.植入式心脏复律除颤器（ICD）和心脏再同步治疗（CRT）的新适应症
Cardiol Clin. 2014 May;32(2):181-90. doi: 10.1016/j.ccl.2013.12.004. Epub 2014 Feb 21.
6
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.
7
Cardiac resynchronization and implantable defibrillators in adults with congenital heart disease.先天性心脏病成人患者的心脏再同步化治疗与植入式心脏除颤器
Heart Fail Rev. 2020 Jul;25(4):657-670. doi: 10.1007/s10741-019-09886-y.
8
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.心脏再同步治疗可减少原发性而非继发性预防性植入式心律转复除颤器患者的室性心律失常：来自门诊心力衰竭试验中再同步治疗的见解。
Circ Arrhythm Electrophysiol. 2017 Mar;10(3). doi: 10.1161/CIRCEP.116.004875.
9
Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.在 MADIT-CRT 中，那些改善程度超过除颤器指南建议的患者发生室性心律失常事件的风险。
JACC Clin Electrophysiol. 2019 Oct;5(10):1172-1181. doi: 10.1016/j.jacep.2019.08.009. Epub 2019 Oct 2.
10
Implantable cardioverter defibrillators and cardiac resynchronisation therapy.植入式心脏转复除颤器和心脏再同步治疗。
Lancet. 2011 Aug 20;378(9792):722-30. doi: 10.1016/S0140-6736(11)61228-2.
引用本文的文献
1
AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring.心脏肿瘤学中的人工智能与智能设备：心脏毒性预测和心血管监测的进展
Diagnostics (Basel). 2025 Mar 20;15(6):787. doi: 10.3390/diagnostics15060787.
2
Recent Advances in Cardiac Resynchronization Therapy: Current Treatment and Future Direction.心脏再同步治疗的最新进展：当前治疗方法与未来方向
J Clin Med. 2025 Jan 29;14(3):889. doi: 10.3390/jcm14030889.
3
Comparison of Single-Coil Versus Dual-Coil Implantable Cardioverter Defibrillator Devices: A Systematic Review and Meta-Analysis of Efficacy and Extraction-Related Outcomes.单线圈与双线圈植入式心脏复律除颤器装置的比较：疗效及与拔除相关结局的系统评价和荟萃分析
Clin Cardiol. 2025 Feb;48(2):e70083. doi: 10.1002/clc.70083.
4
Comparative efficacy of single-coil versus dual-coil ICD leads: a meta-analysis of clinical outcomes.单线圈与双线圈植入式心律转复除颤器（ICD）导线的比较疗效：临床结局的荟萃分析
Future Cardiol. 2025 Mar;21(3):167-175. doi: 10.1080/14796678.2025.2459542. Epub 2025 Jan 30.
5
Innovative Management of Blood Culture-Negative Endocarditis With Pulmonary Septic Emboli in a Patient With a Biventricular Pacemaker and Implantable Cardioverter Defibrillator (BiV-ICD) and Psychosocial Stressors: A Case Report.双心室起搏器和植入式心脏复律除颤器（BiV-ICD）患者合并肺脓毒性栓子的血培养阴性心内膜炎的创新管理及心理社会应激源：一例报告
Cureus. 2024 Jul 22;16(7):e65116. doi: 10.7759/cureus.65116. eCollection 2024 Jul.
6
Sex, Race, and Age Differences in Cardiovascular Outcomes in Implantable Cardioverter-Defibrillator Randomized Controlled Trials: A Systematic Review and Meta-analysis.植入式心脏复律除颤器随机对照试验中心血管结局的性别、种族和年龄差异：一项系统评价和荟萃分析。
CJC Open. 2021 Sep 24;3(12 Suppl):S209-S217. doi: 10.1016/j.cjco.2021.09.015. eCollection 2021 Dec.
7
Pathogenesis and management of Brugada syndrome in schizophrenia: A scoping review.精神分裂症患者 Brugada 综合征的发病机制与治疗管理：范围综述。
Gen Hosp Psychiatry. 2020 Nov-Dec;67:83-91. doi: 10.1016/j.genhosppsych.2020.09.003. Epub 2020 Oct 6.
8
Prognostication of Poor Survival After Cardiac Resynchronization Therapy.心脏再同步化治疗后预后不良的预测。
Medicina (Kaunas). 2020 Jan 4;56(1):19. doi: 10.3390/medicina56010019.
9
Prevalence of non-acute ischaemic cardiomyopathy in a Pakistani cohort.巴基斯坦队列中非急性缺血性心肌病的患病率。
Heart Asia. 2019 Mar 25;11(1):e011043. doi: 10.1136/heartasia-2018-011043. eCollection 2019.
10
Coronary Sinus Stenting for the Management of Left Ventricular Lead Displacement during Resynchronization Therapy: A Report of Two Cases.冠状动脉窦支架置入术治疗心脏再同步化治疗期间左心室电极移位：两例报告
J Tehran Heart Cent. 2018 Jan;13(1):27-31.
本文引用的文献
1
Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?心脏再同步治疗对高龄老人是否可行、安全且有益？
J Geriatr Cardiol. 2015 Sep;12(5):497-501. doi: 10.11909/j.issn.1671-5411.2015.05.003.
2
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).2015年欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防指南：欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防特别工作组。认可机构：欧洲儿科和先天性心脏病协会（AEPC）。
Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29.
3
Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials.心脏再同步治疗与非左束支传导阻滞QRS形态患者的死亡率降低或心力衰竭住院率降低无关：随机对照试验的荟萃分析。
Heart. 2015 Sep;101(18):1456-62. doi: 10.1136/heartjnl-2014-306811. Epub 2015 Feb 12.
4
Left ventricular reverse remodeling, device-related adverse events, and long-term outcome after cardiac resynchronization therapy in the elderly.老年人心脏再同步治疗后的左心室逆向重构、与设备相关的不良事件及长期预后
Circ Cardiovasc Qual Outcomes. 2014 May;7(3):437-44. doi: 10.1161/CIRCOUTCOMES.113.000821. Epub 2014 May 13.
5
Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).心房颤动患者的心脏再同步治疗：CERTIFY 研究（心房颤动患者心脏再同步治疗多国注册研究）。
JACC Heart Fail. 2013 Dec;1(6):500-7. doi: 10.1016/j.jchf.2013.06.003. Epub 2013 Oct 23.
6
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.心脏再同步治疗伴窄 QRS 波群心力衰竭。
N Engl J Med. 2013 Oct 10;369(15):1395-405. doi: 10.1056/NEJMoa1306687. Epub 2013 Sep 2.
7
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南：美国心脏病学会基金会/美国心脏协会报告
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
8
Biventricular pacing for atrioventricular block and systolic dysfunction.双心室起搏治疗房室传导阻滞和收缩功能障碍。
N Engl J Med. 2013 Apr 25;368(17):1585-93. doi: 10.1056/NEJMoa1210356.
9
Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial.超声心动图引导左心室导线放置在心脏再同步治疗中的应用：斑点追踪辅助再同步治疗电极区域试验的结果。
Circ Heart Fail. 2013 May;6(3):427-34. doi: 10.1161/CIRCHEARTFAILURE.112.000078. Epub 2013 Mar 8.
10
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.心力衰竭伴 QRS 波群<120 毫秒患者的心脏再同步治疗：心力衰竭再同步治疗评估（LESSER-EARTH）试验。
Circulation. 2013 Feb 26;127(8):873-81. doi: 10.1161/CIRCULATIONAHA.112.001239. Epub 2013 Feb 6.
Zotero 插件